Aspirin/Omeprazole

阿司匹林/奥美拉唑

Report date: 2024/06/14 20:00:57

Base Information

Drug NameAspirin/Omeprazole
Drug Alias NameAspirin and Omeprazole乙酰水杨酸/奥美拉唑Acetylsalicylic acid/omeprazole奥美拉唑/阿司匹林Omeprazole/Acetylsalicylic acid +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitorsCyclooxygenases inhibitors
TargetsProton pumpCyclooxygenases
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsStomach Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/09/14
Country/TerritoryCanadaUnited StatesMainland China
CombinationsYes AspirinOmeprazole
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAralez Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Hanmi Pharmaceutical Co Ltd
Inactive CompaniesGenus Lifesciences IncAutobahn Therapeutics Inc
Active IndicationsStomach Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A